LY3006072

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3006072, covering 2019-08-08 to 2019-08-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3006072 in Healthy Participants [Phase 1]